Browse studies

Find your next paid study

15 recruiting studies matching your filters

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Oruka Therapeutics, Inc.NCT07783542

Phase 1

A Phase 1b, Open-label Study Evaluating the Safety and Efficacy of Oral Soquelitinib in Adults With Moderate-to-Severe Hidradenitis Suppurativa

Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Corvus Pharmaceuticals, Inc.NCT07828860

Phase 3

A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Incyte CorporationNCT06855498

Phase 2

Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease hidradeni…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

University of Massachusetts, WorcesterNCT07756346

An Observational Study of Patients With Dermatologic Disease

TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who tre…

VitiligoAtopic DermatitisAlopecia Areata+1 more

Estimated

~$10 – $1,050

Target PharmaSolutions, Inc.NCT07748169

Phase 2

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Assess the Efficacy and Safety of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa Receiving Standard of Care Treatment

This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease rec…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Spyre Therapeutics, Inc.NCT07766005

Phase 2

A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidraden…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Incyte CorporationNCT07213973

Phase 2

A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study of NAV-240 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

The main objective of this study is to determine if NAV-240 works more effectively than a dummy treatment (placebo) for participants with moderate-to-severe HS…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $8,750

Navigator Medicines, Inc.NCT07384975

Phase 2

An Open-Label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $7,500

Harrison DermatologyNCT07689188

Phase 2

An Open-label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Hidradenitis Suppurativa

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT07263230

Observational

Outcomes With Pelashield™ PainGuard™ Compared to Restrata® in Standard Two-Stage Excision and Closure for Hidradenitis Suppurativa: A Prospective Cohort With Retrospective Comparator

Hidradenitis Suppurativa (HS) is a long-lasting skin condition that causes painful lumps and infections. In severe cases, patients need surgery to remove the a…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT07316192

Observational

Radiotherapy for Treatment of Recalcitrant Hidradenitis Suppurativa (RADIANT-SUPPoRT)

The goal of this clinical trial is to learn if high-dose radiotherapy can provide sustained disease relief in moderate to severe, treatment resistant Hidradeni…

Hidradenitis Suppurativa (HS)

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07414550